Skip to main content

Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc.

Dadas, O., Allen, J. D., Buchan, S. L., Kim, J., Chan, C. H. T., Mockridge, C. I., Duriez, P. J., Rogel, A., Crispin, M. and Al-Shamkhani, A., 2023. Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc. Frontiers in Immunology, 14, 1252274.

Full text available as:

fimmu-14-1252274.pdf - Published Version
Available under License Creative Commons Attribution.


DOI: 10.3389/fimmu.2023.1252274


Introduction: T cell expressed CD27 provides costimulation upon binding to inducible membrane expressed trimeric CD70 and is required for protective CD8 T cell responses. CD27 agonists could therefore be used to bolster cellular vaccines and anti-tumour immune responses. To date, clinical development of CD27 agonists has focussed on anti-CD27 antibodies with little attention given to alternative approaches. Methods: Here, we describe the generation and activity of soluble variants of CD70 that form either trimeric (t) or dimer-of-trimer proteins and conduct side-by-side comparisons with an agonist anti-CD27 antibody. To generate a dimer-of-trimer protein (dt), we fused three extracellular domains of CD70 to the Fc domain of mouse IgG1 in a ‘string of beads’ configuration (dtCD70-Fc). Results: Whereas tCD70 failed to costimulate CD8 T cells, both dtCD70-Fc and an agonist anti-CD27 antibody were capable of enhancing T cell proliferation in vitro. Initial studies demonstrated that dtCD70-Fc was less efficacious than anti-CD27 in boosting a CD8 T cell vaccine response in vivo, concomitant with rapid clearance of dtCD70-Fc from the circulation. The accelerated plasma clearance of dtCD70-Fc was not due to the lack of neonatal Fc receptor binding but was dependent on the large population of oligomannose type glycosylation. Enzymatic treatment to reduce the oligomannose-type glycans in dtCD70-Fc improved its half-life and significantly enhanced its T cell stimulatory activity in vivo surpassing that of anti-CD27 antibody. We also show that whereas the ability of the anti-CD27 to boost a vaccine response was abolished in Fc gamma receptor (FcγR)-deficient mice, dtCD70-Fc remained active. By comparing the activity of dtCD70-Fc with a variant (dtCD70-Fc(D265A)) that lacks binding to FcγRs, we unexpectedly found that FcγR binding to dtCD70-Fc was required for maximal boosting of a CD8 T cell response in vivo. Interestingly, both dtCD70-Fc and dtCD70-Fc(D265A) were effective in prolonging the survival of mice harbouring BCL1 B cell lymphoma, demonstrating that a substantial part of the stimulatory activity of dtCD70-Fc in this setting is retained in the absence of FcγR interaction. Discussion: These data reveal that TNFRSF ligands can be generated with a tunable activity profile and suggest that this class of immune agonists could have broad applications in immunotherapy.

Item Type:Article
Uncontrolled Keywords:CD27; TNFRSF; costimulation; T cells; cancer; vaccine; immunotherapy
Group:Faculty of Science & Technology
ID Code:39098
Deposited By: Symplectic RT2
Deposited On:07 Nov 2023 13:04
Last Modified:07 Nov 2023 13:04


Downloads per month over past year

More statistics for this item...
Repository Staff Only -